Age-Related Vision-Loss Drug Approved

A new eye medicine from Regeneron Pharmaceuticals Inc. and Bayer AG is safe and effective for treating a common cause of vision loss, a panel of U.S. experts said on Friday. The Food and Drug Administration advisory panel voted unanimously to recommend Eylea as a treatment for the most serious form of macular degeneration that affects at least 1.5 million Americans.
News Max Health